SCHEMBL1474804

SCHEMBL1474804

O=c1[nH]cccc1CN1CCC(O)(CCc2ccccc2F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
CCR8 P51685 1/20 0.40
KCNH2 Q12809 1/20 0.40
USP7 Q93009 1/20 0.40
CYP2A13 Q16696 1/20 0.39
HTR2A P28223 1/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 4/20 0.38
MCHR1 Q99705 1/20 0.38
POLB P06746 2/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 2/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37
COMT P21964 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1475951 0.86 CCR8 (0.42) ALDH1A1CCR8KCNH2CYP2A13KDM4E
SCHEMBL1475313 0.84 MCHR1 (0.39) ALDH1A1USP7HTR2AKDM4EMCHR1
SCHEMBL5400852 0.83 USP7 (0.37) ALDH1A1CCR8KCNH2USP7CYP2A13
SCHEMBL5400845 0.82 TACR1 (0.42) ALDH1A1CCR8KCNH2USP7KMT2A
SCHEMBL12827514 0.81 ALDH1A1 (0.48) ALDH1A1CCR8KCNH2CYP2A13HTR2A
SCHEMBL1476956 0.81 KCNH2 (0.44) ALDH1A1CCR8KCNH2USP7KDM4E
SCHEMBL5400844 0.81 DPP4 (0.38) ALDH1A1CCR8KCNH2USP7CYP2A13
SCHEMBL1475562 0.80 KCNH2 (0.40) ALDH1A1CCR8KCNH2CYP2A13KDM4E
SCHEMBL5400840 0.79 KCNH2 (0.37) ALDH1A1CCR8KCNH2CYP2A13KDM4E
SCHEMBL1474461 0.77 KCNH2 (0.40) ALDH1A1CCR8KCNH2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-7265108-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2007-09-04 US disclosed
US-7265108-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2007-09-04 US disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
US-6995144-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2006-02-07 US disclosed
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
EP-1484327-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF Eisai Co., Ltd. (JP) 2004-12-08 EP disclosed
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 ALDH1A1 363/4885CCR8 1336/4885KCNH2 451/4885
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same NQO1, CBR1, NOX1 ALDH1A1 423/4885CCR8 1016/4885KCNH2 762/4885
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 ALDH1A1 363/4885CCR8 1336/4885KCNH2 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.